What is the CoE Program?

bioMérieux established the Antimicrobial Stewardship Centers of Excellence program in 2021 to bring attention to the threat of antimicrobial resistance (AMR). Our goal is to identify health systems that already are exemplars of AMS—sites that acknowledge the importance of diagnostics in the fight against antimicrobial resistance.

Our partners not only share our passion for public health but also use a portion of our portfolio already; they are interested and willing to engage in continued scientific engagement and research activities to serve as exemplars on what great looks like when it comes to antimicrobial stewardship.

Our United States Partners

bioMérieux is proud to have three incredible partnerships in the fight against AMR. Learn more about how these institutions work tirelessly to improve public health in their communities.

Henry Ford Health

"Antimicrobial resistance continues to be one of the greatest challenges facing the healthcare community, It is critical that we continue to develop the tools to detect resistant pathogens with accuracy and in a timely manner. We are excited to continue in this journey with bioMérieux with the shared goal of leveraging novel technology to improve patient outcomes.” – Linoj Samuel, Ph.D., D (ABMM), Division Head Microbiology.

Tampa General Hospital

“Our program excels because we actually make sure we have the appropriate tools to analyze the test results and apply that information to maximize patient outcomes versus just running tests. We also identify genetic related antimicrobial resistant organisms to control their spread,” “These results make a real difference inside and outside the hospital and as technology improves, the outcomes will only continue to improve.” – Dr. Suzane Silbert, scientific director of esoteric testing, research and development and microbiology laboratories at Tampa General.​

Texas Children’s Hospital

“By collaborating with bioMérieux, we can deliver diagnostic-driven insights that directly impact patient therapy and accelerate our stewardship program impact … Our teams work diligently to engage all Texas Children’s stakeholders in our AMS initiatives. We want to set the best possible example for other health systems that might be figuring out how to get started or overcome barriers. Together, we can all make a difference in the fight against AMR.” –  Dr. James Versalovic, Pathologist-in-Chief at Texas Children’s Hospital and Director of Texas Children’s Microbiome Center and a Milton J. Finegold Professor and Vice Chair, Pathology & Immunology, Baylor College of Medicine.  ​